CAS: 1887014-12-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Olutasidenib REF: TM-T16384CAS: 1887014-12-1 | 98.57% | 61.00 €~1,302.00 € | Wed 22 Jan 25 | |
Olutasidenib REF: IN-DA01FTROCAS: 1887014-12-1 | 97% | To inquire | Wed 22 Jan 25 | |
Olutasidenib REF: TR-O299810CAS: 1887014-12-1 | - - - | 202.00 €~1,523.00 € | Mon 03 Feb 25 | |
Olutasidenib REF: 3D-MAD01412CAS: 1887014-12-1 | Min. 95% | To inquire | Wed 05 Mar 25 |
Olutasidenib
CAS:1887014-12-1
Olutasidenib (FT-2102), an IDH1 inhibitor (IC50: 21.2/114 nM), is studied for treating AML/MDS and can …
Formula:
C18H15ClN4O2
Purity:
98.57%
Color and Shape:
Solid
Molecular weight:
354.79
Ref: TM-T16384
1mg | 61.00 € | ||
5mg | 167.00 € | ||
10mg | 259.00 € | ||
25mg | 477.00 € | ||
50mg | 694.00 € | ||
100mg | 976.00 € | ||
200mg | 1,302.00 € | ||
1mL*10mM (DMSO) | 177.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
Ref: IN-DA01FTRO
50mg | 242.00 € | ||
100mg | 543.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
Ref: TR-O299810
10mg | 202.00 € | ||
50mg | 882.00 € | ||
100mg | 1,523.00 € |
Estimated delivery in United States, on Monday 3 Feb 2025
Olutasidenib
CAS:1887014-12-1
Olutasidenib is a molecule that inhibits the platelet-derived growth factor receptor alpha (PDGFRα) and is …
Formula:
C18H15ClN4O2
Purity:
Min. 95%
Molecular weight:
354.79 g/mol
Ref: 3D-MAD01412
25mg | 1,180.00 € | ||
50mg | 1,642.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025